Gallbladder cancer laboratory tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (17 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gallbladder cancer}} | {{Gallbladder cancer}} | ||
{{CMG}} | {{CMG}}{{AE}}{{VKG}} | ||
==Overview== | ==Overview== | ||
There are some [[diagnostic]] laboratory findings associated with [[gallbladder cancer]], such as [[alkaline phosphatase]], serum [[bilirubin]], carcinoembryonic antigen ([[CEA]]), [[CA 19-9]]. | |||
==Laboratory tests== | ==Laboratory tests== | ||
There are no diagnostic laboratory findings associated with [[gallbladder carcinoma]].<ref name="pmid2335386">{{cite journal |vauthors=Strom BL, Maislin G, West SL, Atkinson B, Herlyn M, Saul S, Rodriguez-Martinez HA, Rios-Dalenz J, Iliopoulos D, Soloway RD |title=Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer? |journal=Int. J. Cancer |volume=45 |issue=5 |pages=821–4 |year=1990 |pmid=2335386 |doi= |url=}}</ref><ref name="pmid21573879">{{cite journal |vauthors=Rana S, Dutta U, Kochhar R, Rana SV, Gupta R, Pal R, Jain K, Srinivasan R, Nagi B, Nain CK, Singh K |title=Evaluation of CA 242 as a tumor marker in gallbladder cancer |journal=J Gastrointest Cancer |volume=43 |issue=2 |pages=267–71 |year=2012 |pmid=21573879 |doi=10.1007/s12029-011-9288-7 |url=}}</ref> | |||
Laboratory findings consistent with the diagnosis of [[gallbladder carcinoma]] include: | |||
* An elevated [[alkaline phosphatase]] or serum [[bilirubin]] can be associated with [[bile duct]] [[obstruction]]. | |||
*<nowiki/><nowiki/><nowiki/>Serum [[tumor marker]]<nowiki/>s including [[carcinoembryonic antigen]] ([[CEA]]) or [[carbohydrate]] [[antigen]] 19-9 are frequently elevated, but they have lack of [[specificity]] and [[sensitivity]]. | |||
*<nowiki/> <nowiki/>CA 242 is a tumor <nowiki/>marker for [[gallbladder cancer]] and performs better than [[CEA]] and [[CA 19-9]].<ref name="pmid24744600">{{cite journal |vauthors=Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, Jiang XQ, Peng ZH |title=Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer |journal=World J. Gastroenterol. |volume=20 |issue=14 |pages=4085–92 |date=April 2014 |pmid=24744600 |pmc=3983467 |doi=10.3748/wjg.v20.i14.4085 |url=}}</ref><ref name="pmid26421012">{{cite journal |vauthors=Kanthan R, Senger JL, Ahmed S, Kanthan SC |title=Gallbladder Cancer in the 21st Century |journal=J Oncol |volume=2015 |issue= |pages=967472 |date=2015 |pmid=26421012 |doi=10.1155/2015/967472 |url=}}</ref> | |||
*<nowiki/>However, if a tumo<nowiki/>r marker is observed to be elevated preoperatively, serial assay after [[resection]] may useful resource within the analysis of chronic or recurrent disease. | |||
==References== | ==References== | ||
Latest revision as of 00:13, 13 January 2019
|
Gallbladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gallbladder cancer laboratory tests On the Web |
|
American Roentgen Ray Society Images of Gallbladder cancer laboratory tests |
|
Risk calculators and risk factors for Gallbladder cancer laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
There are some diagnostic laboratory findings associated with gallbladder cancer, such as alkaline phosphatase, serum bilirubin, carcinoembryonic antigen (CEA), CA 19-9.
Laboratory tests
There are no diagnostic laboratory findings associated with gallbladder carcinoma.[1][2]
Laboratory findings consistent with the diagnosis of gallbladder carcinoma include:
- An elevated alkaline phosphatase or serum bilirubin can be associated with bile duct obstruction.
- Serum tumor markers including carcinoembryonic antigen (CEA) or carbohydrate antigen 19-9 are frequently elevated, but they have lack of specificity and sensitivity.
- CA 242 is a tumor marker for gallbladder cancer and performs better than CEA and CA 19-9.[3][4]
- However, if a tumor marker is observed to be elevated preoperatively, serial assay after resection may useful resource within the analysis of chronic or recurrent disease.
References
- ↑ Strom BL, Maislin G, West SL, Atkinson B, Herlyn M, Saul S, Rodriguez-Martinez HA, Rios-Dalenz J, Iliopoulos D, Soloway RD (1990). "Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer?". Int. J. Cancer. 45 (5): 821–4. PMID 2335386.
- ↑ Rana S, Dutta U, Kochhar R, Rana SV, Gupta R, Pal R, Jain K, Srinivasan R, Nagi B, Nain CK, Singh K (2012). "Evaluation of CA 242 as a tumor marker in gallbladder cancer". J Gastrointest Cancer. 43 (2): 267–71. doi:10.1007/s12029-011-9288-7. PMID 21573879.
- ↑ Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, Jiang XQ, Peng ZH (April 2014). "Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer". World J. Gastroenterol. 20 (14): 4085–92. doi:10.3748/wjg.v20.i14.4085. PMC 3983467. PMID 24744600.
- ↑ Kanthan R, Senger JL, Ahmed S, Kanthan SC (2015). "Gallbladder Cancer in the 21st Century". J Oncol. 2015: 967472. doi:10.1155/2015/967472. PMID 26421012.